Precede Biosciences

Boston, MA · Founded 2021 · Privately Held (backing)

Developer of a liquid biopsy platform designed to provide resolution into disease-defining biology from a blood test. Precede Biosciences is based in Boston, MA and was founded in 2021. Its last reported valuation was $199 million in Oct 2025. It has raised $132 million.

Last reported valuation

$198.5M

Oct 2026

Priced at

—

Total raised

$132.0M

Last round

—

How much has Precede Biosciences raised?

$132.0Macross 0 recorded rounds

Free account

More of Precede Biosciences with a free account

·The complete investor list: 17 names
·Watch Precede Biosciences: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Precede Biosciences investors

17 investors are on record for Precede Biosciences, including Alexandria Venture Investments, Mirae Asset Capital, Qatar Investment Authority and Osage University Partners. By type, the record holds 6 venture capital firms, 1 asset manager and 1 private equity firm.

For fundraisers

Raising for a company like Precede Biosciences?

17 investors have backed Precede Biosciences.

See all 17 investors →

Frequently asked about Precede Biosciences

How much has Precede Biosciences raised?: Precede Biosciences has raised $132.0M in total across 0 recorded funding rounds.